GENEVA, Aug. 21 -- YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. filed a patent application (IL2026/050147) for “PI3K INHIBITORS FOR THE TREATMENT OF SYNUCLEIN-RELATED PATHOLOGIES”. With publication no. WO/2026/172356, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/437
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....